These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32267807)

  • 1. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians.
    Calcaterra SL; Binswanger IA; Edelman EJ; McNair BK; Wakeman SE; O'Connor PG
    Subst Abus; 2022; 43(1):143-151. PubMed ID: 32267807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences with an addiction consultation service on care provided to hospitalized patients with opioid use disorder: a qualitative study of hospitalists, nurses, pharmacists, and social workers.
    Callister C; Lockhart S; Holtrop JS; Hoover K; Calcaterra SL
    Subst Abus; 2022; 43(1):615-622. PubMed ID: 34666634
    [No Abstract]   [Full Text] [Related]  

  • 3. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
    Calcaterra SL; Lockhart S; Callister C; Hoover K; Binswanger IA
    J Gen Intern Med; 2022 Aug; 37(11):2786-2794. PubMed ID: 34981359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors.
    Tesema L; Marshall J; Hathaway R; Pham C; Clarke C; Bergeron G; Yeh J; Soliman M; McCormick D
    Subst Abus; 2018; 39(4):434-440. PubMed ID: 29513136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder.
    Reed MK; Murali V; Sarpoulaki N; Zavodnick JH; Hom JK; Rising KL
    Drug Alcohol Depend Rep; 2022 Dec; 5():100106. PubMed ID: 36844165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.
    Foti K; Heyward J; Tajanlangit M; Meek K; Jones C; Kolodny A; Alexander GC
    Drug Alcohol Depend; 2021 Aug; 225():108811. PubMed ID: 34175786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with frequent buprenorphine / naloxone initiation in a national survey of Canadian emergency physicians.
    MacKinnon N; Lane D; Scheuermeyer F; Kaczorowski J; Dong K; Orkin AM; Daoust R; Moe J; Andolfatto G; Klaiman M; Yan J; Koh JJ; Crowder K; Atkinson P; Savage D; Stempien J; Besserer F; Wale J; Kestler A
    PLoS One; 2024; 19(2):e0297084. PubMed ID: 38315732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a comprehensive hospitalist-led initiative to improve care for patients with opioid use disorder.
    Clifton D; Ivey N; Poley S; O'Regan A; Raman SR; Frascino N; Hamilton S; Setji N
    J Hosp Med; 2022 Jun; 17(6):427-436. PubMed ID: 35535562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder.
    Callister C; Porter S; Vatterott P; Keniston A; McBeth L; Mann S; Calcaterra SL; Limes J
    Subst Use Addctn J; 2024 Jul; 45(3):356-366. PubMed ID: 38258815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Resident Physicians' Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder.
    Shuey B; Lee D; Ugalde I; Borgan S; Bresnan C; Qureshi M; Mhaskar R; Oxner A
    J Addict Med; 2021 May-Jun 01; 15(3):219-225. PubMed ID: 33079729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.
    Muzyk A; Smothers ZPW; Collins K; MacEachern M; Wu LT
    Subst Abus; 2019; 40(4):476-483. PubMed ID: 31418645
    [No Abstract]   [Full Text] [Related]  

  • 13. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
    Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
    Carswell N; Angermaier G; Castaneda C; Delgado F
    Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Qualitative Analysis of Hospitalist Perceptions of Self-Directed Discharge Among Inpatients with Opioid Use Disorder.
    Reed MK; Sarpoulaki N; Murali V; Weinstein LC; Zavodnick JH; Bowles J; Rising KL
    Subst Use Misuse; 2023; 58(7):881-888. PubMed ID: 36987991
    [No Abstract]   [Full Text] [Related]  

  • 17. Buprenorphine Waiver Attitudes Among Primary Care Providers.
    Lai B; Croghan I; Ebbert JO
    J Prim Care Community Health; 2022; 13():21501319221112272. PubMed ID: 35822763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Now hospital leaders are paying attention": A qualitative study of internal and external factors influencing addiction consult services.
    Priest KC; Englander H; McCarty D
    J Subst Abuse Treat; 2020 Mar; 110():59-65. PubMed ID: 31952629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of medical providers' attitudes about naloxone and people with opioid use disorder and their self-reported "low-barrier" treatment practices.
    Winograd RP; Coffey B; Nance M; Carpenter R
    Addict Behav Rep; 2023 Dec; 18():100514. PubMed ID: 37680698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.